Table III.
Immunohistochemistry analysis of FASN and 14-3-3ε in normal, primary and metastatic melanoma tissues.
| A, FASN | Intensity scores | ||
|---|---|---|---|
| Normal (n=3) | Negative | 3/3 | |
| Primary melanomas (n=28) | Negative | 14/28 | |
| Weak | 9/28 | ||
| Moderate | 5/28 | ||
| Strong | 0/28 | ||
| Metastatic melanomas (n=29) | Negative | 8/29 | |
| Weak | 11/29 | ||
| Moderate | 10/29 | ||
| Strong | 0/29 | ||
| B, 14-3-3ε | Intensity scores | ||
| Normal (n=3) | Moderate | 3/3 | |
| Primary melanomas (n=28) | Weak | 6/28 | |
| Moderate | 13/28 | ||
| Strong | 9/28 | ||
| Metastatic melanomas (n=30) | Negative | 1/30 | |
| Weak | 2/30 | ||
| Moderate | 10/30 | ||
| Strong | 17/30 | ||
FASN, fatty acid synthase.